Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2Thoracic 1

Conditions

Solid Tumors 6Advanced Solid Tumor 4Solid Tumor, Adult 2Advanced Solid Tumors 2Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumor 1Patients With Advanced or Metastatic Solid Tumors 1Neoplasms 1Metastatic Solid Tumors 1Mesothelioma, Malignant 1Malignant Solid Tumour 1Locally Advanced or Metastatic Solid Tumors 1KRAS Mutant Solid Tumors 1

Interventions

pembrolizumab 7Radiotherapy 3Proton Therapy 3Interleukin-2 3Cyclophosphamide 3spartalizumab 2fludarabine 2Rosuvastatin Calcium 2Paclitaxel 2Ipilimumab 2Immune Checkpoint Inhibitors 2Cetuximab 2Carboplatin 2Blood Specimen Collection 2toripalimab 1tislelizumab 1sotorasib 1peposertib 1pazopanib 1patritumab deruxtecan 1palbociclib 1osimertinib 1niraparib 1neotil 1necitumumab 1mirdametinib 1leronlimab 1lenvatinib 1atezolizumab 1apatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Solid Tumor, Adult × Cetuximab × Other solid neoplasm × Clear all
NCT04585035 2025-03-18

Study to Evaluate D-1553 in Subjects With Solid Tumors

InventisBio Co., Ltd

Phase 1/2 Active not recruiting
180 enrolled
Other solid neoplasmThoracic

Solid Tumor, Adult

NCT03360734 2021-07-12

GATTO

Glycotope GmbH

Phase 1 Completed
50 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡